Dunhill Financial’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3K Sell
3
-3,997
-100% -$11.7K ﹤0.01% 607
2026
Q2
$13K Hold
4,000
– – ﹤0.01% 543
2026
Q1
$9.9K Hold
4,000
– – ﹤0.01% 538
2025
Q4
$8.2K Buy
+4,000
New +$11.5K ﹤0.01% 525

Other funds holding EDIT

Dunhill Financial's EDIT Position: Q3 2026 in Review

Dunhill Financial reduced its Editas Medicine (EDIT) stake by 100% in Q3 2026, selling an estimated $11.7K and leaving 3 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #607.

Dunhill Financial first reported a position in EDIT in Q4 2025 and has held it in 4 quarters since. The position peaked at $13K in Q2 2026. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Dunhill Financial held 3 shares of Editas Medicine worth $10.3K as of Q3 2026.
  • Dunhill Financial sold 3,997 Editas Medicine shares in Q3 2026, an estimated $11.7K.
  • Editas Medicine made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #607 holding.
  • Dunhill Financial first reported a position in Editas Medicine in Q4 2025 and has held it in 4 quarters since.
  • Dunhill Financial's Editas Medicine position peaked at $13K in Q2 2026.
  • 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.